Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02224911 · ClinicalTrials.gov registry record
Use of Laser Interstitial Thermal Therapy in the Focal Treatment of Localized Prostate Cancer
A clinical trial, sponsored by Jonsson Comprehensive Cancer Center.
- Completed
- Registry status
- 8
- Enrollment target
NCT02224911: Completed study, sponsored by Jonsson Comprehensive Cancer Center.
NCT02224911 is a clinical trial that has completed, run by Jonsson Comprehensive Cancer Center. The registered enrollment target is 8 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02224911 has completed, sponsored by Jonsson Comprehensive Cancer Center.
- COMPLETED
- Registry status
- 8 participants
- Enrollment target
Study Summary
This is a pilot, feasibility/exploratory study to evaluate the safety of laser interstitial thermal therapy (LITT) using Visualase in the focal treatment of localized prostate cancer as well as to gather data for the design of future studies.
Interventions
- DEVICE Laser Interstitial Thermal Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2014-09-11 |
| Est. Completion | 2019-10-21 |
What the finished NCT02224911 record still lists
NCT02224911 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 8 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Laser Interstitial Thermal Therapy is the first listed.
NCT02224911 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02224911 about?
NCT02224911 is a clinical study titled "Use of Laser Interstitial Thermal Therapy in the Focal Treatment of Localized Prostate Cancer". This is a pilot, feasibility/exploratory study to evaluate the safety of laser interstitial thermal therapy (LITT) using Visualase in the focal treatment of localized prostate cancer as well as to gather data for the design of future studies.
What is the current status of trial NCT02224911?
This trial is currently completed. The enrollment target is 8 participants. The study started on 2014-09-11. Estimated completion is 2019-10-21.
What interventions are being tested in trial NCT02224911?
The interventions under investigation include: Laser Interstitial Thermal Therapy (DEVICE).
Who is sponsoring clinical trial NCT02224911?
This trial is sponsored by Jonsson Comprehensive Cancer Center, which has 321 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI